AU Patent

AU2019312036B2 — Nebulizer

Assigned to Monash University · Expires 2025-05-22 · 1y expired

What this patent protects

A nebulizer (10) comprising a housing which defines, a chamber that has an outlet to the chamber for the egress of atomised fluid particles from within the chamber. The nebulizer (10) further including solid substrate (11) within the chamber of the housing. A linear channel (12) …

USPTO Abstract

A nebulizer (10) comprising a housing which defines, a chamber that has an outlet to the chamber for the egress of atomised fluid particles from within the chamber. The nebulizer (10) further including solid substrate (11) within the chamber of the housing. A linear channel (12) being formed in the substrate (11) that has a closed base, opposite side walls and an opening that opens through an upper surface of the substrate (11). A vibration generator (17) being attached to the substrate (11) at a position spaced from the channel (12) for generating high frequency vibration that transmits through the substrate (11) to the channel (12) to atomise fluid within the channel (12). A feeding facility (15) being provided for feeding fluid to the channel (12).

Drugs covered by this patent

Patent Metadata

Patent number
AU2019312036B2
Jurisdiction
AU
Classification
Expires
2025-05-22
Drug substance claim
No
Drug product claim
No
Assignee
Monash University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.